Loomis Sayles & Co. L P purchased a new stake in Amrize Ltd (NYSE:AMRZ – Free Report) in the 2nd quarter, Holdings Channel.com reports. The institutional investor purchased 175,089 shares of the company’s stock, valued at approximately $8,676,000.
A number of other hedge funds have also modified their holdings of AMRZ. Allspring Global Investments Holdings LLC bought a new stake in Amrize during the second quarter worth about $62,646,000. Credit Industriel ET Commercial acquired a new position in shares of Amrize in the second quarter valued at about $109,000. TD Asset Management Inc bought a new position in shares of Amrize during the second quarter worth approximately $8,190,000. Generali Asset Management SPA SGR bought a new position in Amrize during the 2nd quarter worth $4,923,000. Finally, Allianz Asset Management GmbH acquired a new position in Amrize in the second quarter valued at about $158,530,000.
Insiders Place Their Bets
In related news, CTO Roald Brouwer purchased 4,000 shares of Amrize stock in a transaction dated Friday, October 31st. The stock was purchased at an average cost of $51.77 per share, for a total transaction of $207,080.00. Following the completion of the purchase, the chief technology officer directly owned 9,000 shares of the company’s stock, valued at $465,930. The trade was a 80.00% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Jan Philipp Jenisch purchased 55,000 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were purchased at an average price of $52.64 per share, with a total value of $2,895,200.00. Following the completion of the purchase, the chief executive officer owned 1,505,000 shares in the company, valued at approximately $79,223,200. This trade represents a 3.79% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 65,000 shares of company stock worth $3,399,720 in the last 90 days.
Wall Street Analyst Weigh In
Check Out Our Latest Report on Amrize
Amrize Price Performance
AMRZ opened at $52.02 on Tuesday. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. The stock’s 50 day moving average is $49.19. The company has a market cap of $28.77 billion and a price-to-earnings ratio of 28.27. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $56.29.
Amrize (NYSE:AMRZ – Get Free Report) last announced its quarterly earnings results on Wednesday, October 29th. The company reported $0.98 EPS for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.03). The company had revenue of $3.68 billion during the quarter, compared to the consensus estimate of $3.49 billion. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
- Five stocks we like better than Amrize
- Conference Calls and Individual Investors
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- What is a Secondary Public Offering? What Investors Need to Know
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Go on a Shopping Spree With 3 Top Retail ETFs
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
